Docoh
Loading...

CALA Calithera Biosciences

Employees

Data from SEC filings
Employee count

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
On June 11, 2021, Calithera Biosciences, Inc. (“Calithera”) held its 2021 Virtual Annual Meeting of Stockholders (the “Annual Meeting”) via live webcast originating from San Francisco, California. At the Annual Meeting, Calithera’s stockholders voted on four proposals, each of which is described in more detail in Calithera’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 21, 2021. The following is a brief description of each matter voted upon and the results, including the number of votes cast for and against each matter and, if applicable, the number of abstentions and broker non-votes with respect to each matter.

Proposal 1. Stockholders elected the three nominees for Class I directors to serve until Calithera’s 2024 Annual Meeting of Stockholders or until his or her respective successor has been duly elected and qualified. The voting results were as follows:

Director NameVotes ForVotes
Withheld
Broker
Non-Votes
Sunil Agarwal M.D.46,764,4615,010,03810,194,154
Scott Garland51,106,574667,92510,194,154
Jean M. George46,744,4315,030,06810,194,154


Proposal 2. Stockholders ratified the selection by the Audit Committee of the Board of Directors of Calithera of Ernst & Young LLP as Calithera’s independent registered public accounting firm for the year ending December 31, 2021. The voting results were as follows:

Votes ForVotes
Against
AbstentionsBroker
Non-Votes
61,427,667407,258133,7280


Proposal 3. Stockholders approved, on an advisory basis, the compensation of the Calithera’s named executive officers, as disclosed in the proxy statement. The voting results were as follows:

Votes ForVotes
Against
AbstentionsBroker
Non-Votes
49,595,1032,077,387102,00910,194,154